Carlos Gorbea
- Molecular Biology top 10%
- Cell Biology top 2%
- Oncology top 10%
- Cancer Research top 10%
- Epidemiology
- Co-authors
- Martin RechsteinerRen‐Ming DaiChou-Chi H. LiDan L. LongoJudith BondYong LiRobert BenezraDavid Mahaffey
- Topics
- Ubiquitin and proteasome pathways (12 papers)Peptidase Inhibition and Analysis (9 papers)RNA modifications and cancer (6 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Carlos Gorbea
28 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 98
- Molecular Biology 965
- Cell Biology 508
- Oncology 315
- Cancer Research 221
- Epidemiology 211
Countries citing papers authored by Carlos Gorbea
This map shows the geographic impact of Carlos Gorbea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Gorbea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Gorbea more than expected).
Fields of papers citing papers by Carlos Gorbea
This network shows the impact of papers produced by Carlos Gorbea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Gorbea. The network helps show where Carlos Gorbea may publish in the future.
Co-authorship network of co-authors of Carlos Gorbea
This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Gorbea. A scholar is included among the top collaborators of Carlos Gorbea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Gorbea. Carlos Gorbea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 2 | |
| 3 | 80 | |
| 4 | 6 | |
| 5 | 45 | |
| 6 | 12 | |
| 7 | 16 | |
| 8 | 126 | |
| 9 | 62 | |
| 10 | 21 | |
| 11 | 29 | |
| 12 | 62 | |
| 13 | 70 | |
| 14 | 50 | |
| 15 | 32 | |
| 16 | 5 | |
| 17 | 271 | |
| 18 | 65 | |
| 19 | 8 | |
| 20 | 31 |
About Carlos Gorbea
Carlos Gorbea is a scholar working on Cancer Research, Applied Microbiology and Biotechnology and Oncology, having authored 28 papers that have together received 1.5k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (12 papers), Peptidase Inhibition and Analysis (9 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Cell Biology (508 citations), Applied Microbiology and Biotechnology (45 citations) and Cancer Research (221 citations). Carlos Gorbea has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Martin Rechsteiner, Ren‐Ming Dai, Chou-Chi H. Li, Dan L. Longo, Judith Bond, Yong Li, Robert Benezra, David Mahaffey, Demián Cazalla and Daniel Taillandier. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.